Delivery Order SPE2DB22D3301-SPE2DB25FY2QU
Award Date
4/3/25
Potential Completion Date
4/24/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of KEDRAB, a 300 unit/2 ml vial medication. The $3,990.36 firm fixed price delivery order contract has a completion date of June 25, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.36, is a Delivery Order for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, with an ultimate completion date of April 28, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.20 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to Amerisourcebergen Drug Corp is a $2,660.24 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is not set aside and has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,746.22 firm-fixed-price delivery order is for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,712.20, is for the delivery of 1,500 units of the medication KEDRAB (10 ML vial) to support military healthcare programs. It is a firm fixed-price delivery order contract with a completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.40, is for the supply of 1,500 units of the medication KEDRAB, a 10 ML vial. The contract has a firm fixed price pricing type and a period of performance through April 11, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is a Delivery Order with a Firm Fixed Price of $3,325.30 and an Ultimate Completion Date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product KEDRAB 1500U 10ML 1S, with a firm fixed price of $4,873.11 and a completion date of February 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...